CTEV vs PATH
Claritev Corporation (CTEV) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Claritev Corporation (CTEV) is a health information services company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CTEV revenue for 2024-12-31 was $930.6M. Net income was -$1.65B. Revenue was down 3.2% from 2023-12-31 to 2024-12-31. CTEV currently screens at market cap $440.5M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CTEV currently screens at market cap $440.5M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CTEV and PATH stock pages for the full models.
Not investment advice.